Skip to main navigation Skip to search Skip to main content

Thyroid autoantibodies in Thai type 1 diabetic patients: Clinical significance and their relationship with glutamic acid decarboxylase antibodies

  • Chatchalit Rattarasarn
  • , Manuel Aguilar Diosdado
  • , Jose Ortego
  • , Rattana Leelawattana
  • , Supamai Soonthornpun
  • , Worawong Setasuban
  • , Somchit Jaruratanasirikul
  • , Narumon Patarakijvanich
  • Prince of Songkla University
  • Hospital Universitario Puerta del Mar

Research output: Contribution to journal › Article › peer-review

27 Citations (Scopus)

Abstract

Objective: To study the clinical significance of thyroid autoantibodies in Thai patients with type 1 diabetes and their relationship with glutamic acid decarboxylase antibodies (GAD65Ab). Methods: Thyroglobulin antibodies (TG-Ab) and thyroid peroxidase antibodies (TPO-Ab) were measured in 50 Thai type 1 diabetic patients. Forty-four patients also had GAD65Ab measured. Serum thyrotropin (TSH) was measured in all patients who had no history of thyroid disease regardless of thyroid antibody status. Clinical data including sex, age at onset and duration of diabetes, family history of diabetes, fasting c-peptide levels as well as frequencies of GAD65Ab were compared between patients with and without thyroid antibodies. GAD65Ab was also measured in 29 non-diabetic patients with hyperthyroid Graves' disease or Hashimoto thyroiditis as a control group. Results: TG-Ab and TPO-Ab were positive in nine (18%) and 15 (30%) patients, respectively. Eight patients (16%) were positive for both antibodies. Two of 16 patients who were positive for TG-Ab or TPO-Ab had a previous history of hyperthyroidism prior to diabetes onset. Of the remainder, two were newly diagnosed with hyperthyroidism and one was found to have clinical hypothyroidism at the time of the study. None of 34 patients without thyroid antibodies had thyroid dysfunction. Eight patients with positive thyroid antibodies but without clinical thyroid dysfunction and 21 patients without thyroid antibodies were followed for up to 3 years, two patients of the first group developed hypothyroidism, whereas none of the latter developed thyroid dysfunction. The frequency of thyroid dysfunction at the time of initial study was significantly higher in patients with positive thyroid antibodies (3/14 vs. 0/34; P = 0.021) and these patients who were initially euthyroid tended to have a higher risk of developing thyroid dysfunction (2/8 vs. 0/21; P = 0.069). The frequency of thyroid antibodies was significantly increased in females and in those who had positive GAD65Ab. GAD65Ab was negative in all of the non-diabetic patients with autoimmune thyroid disease. Conclusions: About one-fourth of Thai patients with type 1 diabetes without thyroid disease had thyroid antibodies. The frequency of thyroid antibodies was increased in female and in GAD65Ab positive patients. The presence of thyroid antibodies is associated with a higher frequency of and may predict a higher risk for thyroid dysfunction in Thai type 1 diabetic patients. (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)107-111
Number of pages5
JournalDiabetes Research and Clinical Practice
Volume49
Issue number2-3
DOIs
Publication statusPublished - Aug 2000
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Glutamic acid decarboxylase antibody
  • Thyroid antibody
  • Thyroid dysfunction
  • Type 1 diabetes

Fingerprint

Dive into the research topics of 'Thyroid autoantibodies in Thai type 1 diabetic patients: Clinical significance and their relationship with glutamic acid decarboxylase antibodies'. Together they form a unique fingerprint.

Cite this